Boehringer Ingelheim Pharmaceutics Inc (BIPI), founded in 1885 by Albert Boehringer which is located at USA. BIPI focusses primarily in the therapeutic areas of cardiovascular disease, diseases of the central nervous system, metabolic diseases, respiratory diseases, virological diseases and oncology. The main objectives of BIPI can be concised in a single phrase: Value through Innovation. BIPI is dedicated to the discovery, development, manufacture and marketing of highly innovative health care products. BIPI provides the highest quality products to treat various diseases, and bringing more health to patients and their families. BIPI provides an opportunity to think long term about our health care and pharmaceutical research and development to meet the unique challenges and long cycles of drug discovery and development.
The following is the list of scholars from Boehringer Ingelheim Pharmaceutics Inc who contributed and/or serves as editors for one or more OMICS International journals and conferences